Description
Regadenoson is an adenosine A2A receptor agonist that displays vasodilatory activity. Regadenoson is clinically used in myocardial perfusion imaging.
Regadenoson is an adenosine A2A receptor agonist that displays vasodilatory activity. Regadenoson is clinically used in myocardial perfusion imaging.
Cas No. | 313348-27-5 |
---|---|
Purity | ≥99% |
Formula | C15H18N8O5 |
Formula Wt. | 390.35 |
IUPAC Name | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
Info Sheet | R1724 Info Sheet PDF |
---|
Palani G, Ananthasubramaniam K. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev. 2013 Jan-Feb;21(1):42-8. PMID: 22643345.
Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004 Jul 22;94(2A):33D-40D; discussion 40D-42D. PMID: 15261132.